Corpus coverage

319,975 slides

319,974 are described (100%), so the treemap can explain the corpus instead of just counting files.

Total slides
319,975
Described
319,974
Pending
1

Slide type composition

dynamicclickable
Slide type

Showing 319,974 described slides — 100.0% of 319,975 rendered pages

Tile area is proportional to slide count. Click a category to open its subtype map.

all document kinds · all orientations

Slide collection

198,721-198,780 of 319,975

filter-aware
03
The slide uses a numbered list to present five key pillars of the company's value proposition.ATAI | Investor Presentation Deck | 33 slides · atai Life Sciences
Pitch deck Investor relations Loop · Golden Circle1 hit
04
The slide uses a hierarchical structure to connect a high-level objective to three specific operational pillars.ATAI | Investor Presentation Deck | 33 slides · atai Life Sciences
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
05
The slide uses a Gantt-style visualization to represent drug development stages.ATAI | Investor Presentation Deck | 33 slides · atai Life Sciences
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
06
The slide combines a historical achievement list with a forward-looking roadmap and financial runway statement.ATAI | Investor Presentation Deck | 33 slides · atai Life Sciences
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
07
ATAI | Investor Presentation Deck | 33 slidesATAI | Investor Presentation Deck | 33 slides · atai Life Sciences
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
08
Uses a timeline-style visual to represent the 'need' metrics.ATAI | Investor Presentation Deck | 33 slides · atai Life Sciences
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
09
The slide uses a bar chart to show dose-dependent efficacy across three cognitive tests (HVLT, Symbol Coding, Category Fluency).ATAI | Investor Presentation Deck | 33 slides · atai Life Sciences
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
10
The slide uses a vertical process flow to demonstrate the de-risking of the drug candidate.ATAI | Investor Presentation Deck | 33 slides · atai Life Sciences
Pitch deck Investor relations Beat · TractionLoop · Golden Circle1 hit
11
The slide highlights the efficacy of RL-007 in cognitive endpoints during a Phase 2 study.ATAI | Investor Presentation Deck | 33 slides · atai Life Sciences
Pitch deck Investor relations Beat · TractionLoop · Golden Circle1 hit
12
The slide uses a standard clinical trial flow diagram to illustrate the study protocol.ATAI | Investor Presentation Deck | 33 slides · atai Life Sciences
Pitch deck Investor relations Beat · TractionLoop · Golden Circle1 hit
13
The slide uses a feature-comparison matrix to highlight the competitive advantage of RL-007.ATAI | Investor Presentation Deck | 33 slides · atai Life Sciences
Pitch deck Investor relations Beat · Competitive AnalysisLoop · Golden Circle1 hit
14
ATAI | Investor Presentation Deck | 33 slidesATAI | Investor Presentation Deck | 33 slides · atai Life Sciences
Pitch deck Investor relations Beat · Competitive AnalysisLoop · Golden Circle1 hit
15
The slide uses a dual-column layout: left side establishes the scale of the problem (market sizing/context), right side details the clinical pain points.ATAI | Investor Presentation Deck | 33 slides · atai Life Sciences
Pitch deck Investor relations Loop · Golden Circle1 hit
16
The slide uses a line chart to demonstrate the efficacy of different dosages of COMP360 over 12 weeks.ATAI | Investor Presentation Deck | 33 slides · atai Life Sciences
Pitch deck Investor relations Loop · Golden Circle1 hit
17
The slide uses a timeline-based process diagram to illustrate clinical trial protocols.ATAI | Investor Presentation Deck | 33 slides · atai Life Sciences
Pitch deck Investor relations Loop · Golden Circle1 hit
18
The slide uses a split layout: a left-hand sidebar for product summary and a right-hand side for clinical data visualization.ATAI | Investor Presentation Deck | 33 slides · atai Life Sciences
Pitch deck Investor relations Loop · Golden Circle1 hit
19
The slide uses a dark sidebar for product specs and a white main area for trial design and results.ATAI | Investor Presentation Deck | 33 slides · atai Life Sciences
Pitch deck Investor relations Loop · Golden Circle1 hit
20
ATAI | Investor Presentation Deck | 33 slidesATAI | Investor Presentation Deck | 33 slides · atai Life Sciences
Pitch deck Investor relations Loop · Golden Circle1 hit
21
The slide uses a combination of a disease overview, a map-based infographic, and a vertical timeline-style list to highlight the market opportunity.ATAI | Investor Presentation Deck | 33 slides · atai Life Sciences
Pitch deck Investor relations Loop · Golden Circle1 hit
22
The slide uses a split-layout with a left-hand summary table and a right-hand clinical data visualization.ATAI | Investor Presentation Deck | 33 slides · atai Life Sciences
Pitch deck Investor relations Loop · Golden Circle1 hit
23
The slide uses a numbered list to highlight key safety findings alongside a detailed data table.ATAI | Investor Presentation Deck | 33 slides · atai Life Sciences
Pitch deck Investor relations Loop · Golden Circle1 hit
24
The slide uses topographical brain maps to visualize EEG data changes across three cohorts.ATAI | Investor Presentation Deck | 33 slides · atai Life Sciences
Pitch deck Investor relations Loop · Golden Circle1 hit
25
The chart uses error bars and statistical significance markers (asterisks) to compare dose groups against a zero baseline.ATAI | Investor Presentation Deck | 33 slides · atai Life Sciences
Pitch deck Investor relations Loop · Golden Circle1 hit
26
The table uses checkmarks to indicate positive attributes across different drug classes.ATAI | Investor Presentation Deck | 33 slides · atai Life Sciences
Pitch deck Investor relations Loop · Golden Circle1 hit
27
ATAI | Investor Presentation Deck | 33 slidesATAI | Investor Presentation Deck | 33 slides · atai Life Sciences
Pitch deck Investor relations Loop · Golden Circle1 hit
28
Uses a timeline-style visual to list key statistics about the OUD crisis.ATAI | Investor Presentation Deck | 33 slides · atai Life Sciences
Pitch deck Investor relations Loop · Golden Circle1 hit
29
The slide uses a split-layout: a left-hand sidebar for company/product facts and a right-hand main area for clinical data and trial design.ATAI | Investor Presentation Deck | 33 slides · atai Life Sciences
Pitch deck Investor relations Loop · Golden Circle1 hit
30
The slide uses a feature-comparison matrix to highlight the unique value proposition of DMX-1002 (Ibogaine) against standard MAT and withdrawal support drugs.ATAI | Investor Presentation Deck | 33 slides · atai Life Sciences
Pitch deck Investor relations Loop · Golden Circle1 hit
31
ATAI | Investor Presentation Deck | 33 slidesATAI | Investor Presentation Deck | 33 slides · atai Life Sciences
Pitch deck Investor relations Loop · Golden Circle1 hit
32
ATAI | Investor Presentation Deck | 33 slidesATAI | Investor Presentation Deck | 33 slides · atai Life Sciences
Pitch deck Investor relations Loop · Golden Circle1 hit
33
The slide uses a personal narrative to establish the 'why' behind the company's mission.ATAI | Investor Presentation Deck | 33 slides · atai Life Sciences
Pitch deck Investor relations Loop · Golden Circle1 hit
01
Slide 1
Azek | Results Presentation Deck | 16 slidesAzek | Results Presentation Deck | 16 slides · The AZEK Company
Conference presentation Investor relations Beat · Current Situation1 hit
02
Azek | Results Presentation Deck | 16 slidesAzek | Results Presentation Deck | 16 slides · The AZEK Company
Conference presentation Investor relations Beat · Current Situation1 hit
03
Azek | Results Presentation Deck | 16 slidesAzek | Results Presentation Deck | 16 slides · The AZEK Company
Conference presentation Investor relations Beat · Current Situation1 hit
04
The slide uses a temple metaphor to represent strategic pillars.Azek | Results Presentation Deck | 16 slides · The AZEK Company
Conference presentation Investor relations Beat · Current SituationLoop · Cost Of Inaction1 hit
05
Azek | Results Presentation Deck | 16 slidesAzek | Results Presentation Deck | 16 slides · The AZEK Company
Conference presentation Investor relations Beat · Current SituationLoop · Cost Of Inaction1 hit
06
Includes year-over-year percentage changes and basis point changes for EBITDA margin.Azek | Results Presentation Deck | 16 slides · The AZEK Company
Conference presentation Investor relations Beat · Financial ResultsLoop · Cost Of Inaction1 hit
07
The slide uses a side-by-side comparison of GAAP and Non-GAAP metrics, utilizing bar charts to show year-over-year changes.Azek | Results Presentation Deck | 16 slides · The AZEK Company
Conference presentation Investor relations Beat · Financial ResultsLoop · Cost Of Inaction1 hit
08
Includes segment-specific commentary on inventory, M&A, and pricing.Azek | Results Presentation Deck | 16 slides · The AZEK Company
Conference presentation Investor relations Beat · Financial ResultsLoop · Cost Of Inaction1 hit
09
Includes definitions for Working Capital and Gross Debt in the footer.Azek | Results Presentation Deck | 16 slides · The AZEK Company
Conference presentation Investor relations Beat · Financial ResultsLoop · Cost Of Inaction1 hit
10
The table highlights that all 2023 considerations remain consistent with the previous quarter's outlook.Azek | Results Presentation Deck | 16 slides · The AZEK Company
Conference presentation Investor relations Beat · Future OutlookLoop · Cost Of Inaction1 hit
11
Includes footnotes regarding EBITDA reconciliation, depreciation, and share repurchases.Azek | Results Presentation Deck | 16 slides · The AZEK Company
Conference presentation Investor relations Beat · Future Outlook1 hit
12
Includes footnotes regarding GAAP reconciliation and prior year depreciation.Azek | Results Presentation Deck | 16 slides · The AZEK Company
Conference presentation Investor relations Beat · Future Outlook1 hit
13
Azek | Results Presentation Deck | 16 slidesAzek | Results Presentation Deck | 16 slides · The AZEK Company
Conference presentation Investor relations Beat · Conclusion1 hit
14
Includes footnotes explaining acquisition costs and other costs.Azek | Results Presentation Deck | 16 slides · The AZEK Company
Conference presentation Investor relations Beat · Conclusion1 hit
15
Includes detailed footnotes explaining adjustments for stock-based compensation, acquisition costs, and tax impacts.Azek | Results Presentation Deck | 16 slides · The AZEK Company
Conference presentation Investor relations Beat · Conclusion1 hit
16
Includes a list of subsidiary brand logos at the bottom.Azek | Results Presentation Deck | 16 slides · The AZEK Company
Conference presentation Investor relations Beat · Conclusion1 hit
01
Slide 1
Azerion | Results Presentation Deck | 15 slidesAzerion | Results Presentation Deck | 15 slides · Azerion
Conference presentation Investor relations Beat · Attention1 hit
02
Azerion | Results Presentation Deck | 15 slidesAzerion | Results Presentation Deck | 15 slides · Azerion
Conference presentation Investor relations Beat · Attention1 hit
03
Azerion | Results Presentation Deck | 15 slidesAzerion | Results Presentation Deck | 15 slides · Azerion
Conference presentation Investor relations Beat · Attention1 hit
04
Azerion | Results Presentation Deck | 15 slidesAzerion | Results Presentation Deck | 15 slides · Azerion
Conference presentation Investor relations Beat · Attention1 hit
05
The diagram illustrates a value chain or ecosystem flow.Azerion | Results Presentation Deck | 15 slides · Azerion
Conference presentation Investor relations Beat · Need1 hit
06
The slide uses a table-like structure to align strategic pillars with specific performance outcomes.Azerion | Results Presentation Deck | 15 slides · Azerion
Conference presentation Investor relations Beat · Need1 hit
07
The slide uses a bar chart for revenue trends and a sunburst/donut chart for revenue split.Azerion | Results Presentation Deck | 15 slides · Azerion
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
08
The slide uses a custom value-chain style flow diagram to map demand, adtech infrastructure, supply, and revenue streams.Azerion | Results Presentation Deck | 15 slides · Azerion
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
09
Azerion | Results Presentation Deck | 15 slidesAzerion | Results Presentation Deck | 15 slides · Azerion
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
10
Includes three distinct chart types: grouped bar, waterfall, and bridge/waterfall for debt.Azerion | Results Presentation Deck | 15 slides · Azerion
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
11
The slide uses a combination of stacked bar charts and line charts to illustrate performance trends.Azerion | Results Presentation Deck | 15 slides · Azerion
Conference presentation Investor relations Beat · ActionLoop · Pareto Focus1 hit
12
The slide uses a dual-chart layout to contrast operational KPIs (DAU, ARPDAU) with financial KPIs (Net Revenue, Adj EBITDA).Azerion | Results Presentation Deck | 15 slides · Azerion
Conference presentation Investor relations Beat · ActionLoop · Pareto Focus1 hit
13
The slide outlines three pillars of value optimization with a specific target of EUR 10m in annualised savings.Azerion | Results Presentation Deck | 15 slides · Azerion
Conference presentation Investor relations Beat · ActionLoop · Pareto Focus1 hit